Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eloïse Thomas

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer & Metabolism|October 15, 2021
3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiationIrini Skaripa-Koukelli, David Hauton, John Walsby-Tickle, et al.
International Journal of Nanomedicine|October 14, 2017
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastomaEloïse Thomas, Ludovic Colombeau, Mickaël Gries, et al.
Nanomedicine (London, England)|June 17, 2017
<sup>68</sup>Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapyPenelope Bouziotis, Dimitris Stellas, Eloïse Thomas, et al.
RSC Advances|May 9, 2022
Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imagingVivek Thakare, Vu-Long Tran, Marco Natuzzi, et al.
ACS Nano|February 24, 2015
Long-term in vivo clearance of gadolinium-based AGuIX nanoparticles and their biocompatibility after systemic injectionLucie Sancey, Shady Kotb, Charles Truillet, et al.
The British Journal of Radiology|September 19, 2018
AGuIXFrançois Lux, Vu Long Tran, Eloïse Thomas, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer & Metabolism|October 15, 2021
3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiationIrini Skaripa-Koukelli, David Hauton, John Walsby-Tickle, et al.
International Journal of Nanomedicine|October 14, 2017
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastomaEloïse Thomas, Ludovic Colombeau, Mickaël Gries, et al.
Nanomedicine (London, England)|June 17, 2017
<sup>68</sup>Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapyPenelope Bouziotis, Dimitris Stellas, Eloïse Thomas, et al.
RSC Advances|May 9, 2022
Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imagingVivek Thakare, Vu-Long Tran, Marco Natuzzi, et al.
ACS Nano|February 24, 2015
Long-term in vivo clearance of gadolinium-based AGuIX nanoparticles and their biocompatibility after systemic injectionLucie Sancey, Shady Kotb, Charles Truillet, et al.
The British Journal of Radiology|September 19, 2018
AGuIXFrançois Lux, Vu Long Tran, Eloïse Thomas, et al.
Pageof 1